Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
7
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| LoConti Joseph E. | 10% Owner | 8 | $1.02M | $0 | 2023-12-14 |
| Indemnity National Insurance Co | 10% Owner | 3 | $1.00M | $0 | 2023-10-30 |
| FEIGHAN EDWARD F | Director | 9 | $60.0K | $0 | 2023-04-28 |
| Zipp Brandon Joel | Chief Science Officer | 8 | $0 | $0 | 2021-12-10 |
| Cavanaugh Michael R. | Chief Executive Officer | 1 | $0 | $0 | 2021-12-10 |
| MCKILLIGAN RICHARD | Chief Financial Officer | 6 | $0 | $0 | 2021-12-10 |
| Celeste Richard F | Director | 1 | $0 | $0 | 2021-12-10 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| LoConti Joseph E. | 10% Owner | P Buy | 2023-12-14 | 2023-12-14 | 16,225 | $0.18 | $2.9K | 4,818,434 | SEC↗ |
| LoConti Joseph E. | 10% Owner | P Buy | 2023-12-13 | 2023-12-14 | 1,400 | $0.18 | $252 | 4,802,209 | SEC↗ |
| LoConti Joseph E. | 10% Owner | P Buy | 2023-12-12 | 2023-12-14 | 35,812 | $0.15 | $5.4K | 4,747,463 | SEC↗ |
| LoConti Joseph E. | 10% Owner | P Buy | 2023-12-12 | 2023-12-14 | 53,346 | $0.16 | $8.5K | 4,800,809 | SEC↗ |
| LoConti Joseph E. | 10% Owner | D To issuer deriv | 2023-10-30 | 2023-11-03 | 6,666,667 | — | $0 | 0 | SEC↗ |
| Indemnity National Insurance C | 10% Owner | S Sale deriv | 2023-10-30 | 2023-11-07 | 13,333,333 | — | $0 | 0 | SEC↗ |
| LoConti Joseph E. | 10% Owner | P Buy | 2023-10-30 | 2023-11-03 | 666,667 | — | $0 | 13,463,813 | SEC↗ |
| Indemnity National Insurance C | 10% Owner | P Buy | 2023-10-30 | 2023-11-07 | 1,333,333 | — | $0 | 21,333,333 | SEC↗ |
| Indemnity National Insurance C | 10% Owner | P Buy | 2023-08-24 | 2023-08-29 | 6,666,667 | $0.15 | $1.00M | 33,333,333 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-28 | 2023-05-04 | 30,000 | $0.20 | $6.0K | 2,389,022 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-26 | 2023-05-04 | 2,000 | $0.20 | $400 | 2,359,022 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-25 | 2023-05-04 | 2,000 | $0.20 | $400 | 2,357,022 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-21 | 2023-05-04 | 10,000 | $0.20 | $2.0K | 2,355,022 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-21 | 2023-05-04 | 5,000 | $0.20 | $1.0K | 2,345,022 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-19 | 2023-05-04 | 1,000 | $0.18 | $180 | 2,340,022 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy deriv | 2023-04-11 | 2023-04-13 | 333,333 | — | $0 | 1,583,333 | SEC↗ |
| FEIGHAN EDWARD F | Director | P Buy | 2023-04-11 | 2023-04-13 | 333,333 | $0.15 | $50.0K | 2,339,022 | SEC↗ |
| LoConti Joseph E. | 10% Owner | A Award deriv | 2022-05-10 | 2022-05-12 | 6,666,667 | — | $0 | 6,666,667 | SEC↗ |
| LoConti Joseph E. | 10% Owner | P Buy | 2022-05-10 | 2022-05-12 | 6,666,667 | $0.15 | $1.00M | 12,797,146 | SEC↗ |
| MCKILLIGAN RICHARD | Chief Financial Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 20,000 | — | $0 | 0 | SEC↗ |
| MCKILLIGAN RICHARD | Chief Financial Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 10,000 | — | $0 | 0 | SEC↗ |
| MCKILLIGAN RICHARD | Chief Financial Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 20,000 | — | $0 | 0 | SEC↗ |
| MCKILLIGAN RICHARD | Chief Financial Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 75,000 | — | $0 | 0 | SEC↗ |
| MCKILLIGAN RICHARD | Chief Financial Officer | A Award deriv | 2021-12-10 | 2021-12-13 | 114,769 | — | $0 | 114,769 | SEC↗ |
| MCKILLIGAN RICHARD | Chief Financial Officer | A Award deriv | 2021-12-10 | 2021-12-13 | 35,231 | — | $0 | 150,000 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 2,500 | — | $0 | 0 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | A Award deriv | 2021-12-10 | 2021-12-13 | 22,513 | — | $0 | 150,000 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | A Award deriv | 2021-12-10 | 2021-12-13 | 127,487 | — | $0 | 127,487 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 7,500 | — | $0 | 0 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 75,000 | — | $0 | 0 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 20,000 | — | $0 | 0 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 20,000 | — | $0 | 0 | SEC↗ |
| Zipp Brandon Joel | Chief Science Officer | D To issuer deriv | 2021-12-10 | 2021-12-13 | 15,000 | — | $0 | 0 | SEC↗ |
| Celeste Richard F | Director | A Award deriv | 2021-12-10 | 2021-12-13 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Cavanaugh Michael R. | Chief Executive Officer | A Award deriv | 2021-12-10 | 2021-12-13 | 350,000 | — | $0 | 350,000 | SEC↗ |
| FEIGHAN EDWARD F | Director | A Award deriv | 2021-12-10 | 2021-12-13 | 250,000 | — | $0 | 250,000 | SEC↗ |